Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04851119 |
|---|---|
| Brief Title: | Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors |
| First Submitted : | April 12, 2021 |
| First Submitted that Met QC Criteria : | April 16, 2021 |
| First Posted : | April 20, 2021 |
| Last Update Submitted that Met QC Criteria : | April 18, 2024 |
| Last Update Posted : | April 22, 2024 |